Nginache Nampota-Nkomba
Overview
Explore the profile of Nginache Nampota-Nkomba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nampota-Nkomba N, Nyirenda O, Datta S, Mapemba V, Patel P, Misiri T, et al.
EClinicalMedicine
. 2025 Mar;
81:103100.
PMID: 40034570
Background: We assessed persistence of typhoid immunity conferred by Vi polysaccharide-tetanus toxoid (Vi-TT) conjugate vaccine (TCV) four years post-vaccination and immunogenicity of a booster dose of Vi-TT given at age...
2.
Nampota-Nkomba N, Nyirenda O, Mapemba V, Masonga R, Patel P, Misiri T, et al.
Hum Vaccin Immunother
. 2024 Sep;
20(1):2384760.
PMID: 39263923
Vaccine safety and immunogenicity data in human immunodeficiency virus (HIV)-exposed uninfected (HEU) children are important for decision-making in HIV and typhoid co-endemic countries. In an open-label study, we recruited Malawian...
3.
Nampota-Nkomba N, Keita A, Juma J, Sidibe D, Kourouma N, Sissoko S, et al.
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae154.
PMID: 38617075
Measles deaths highlight immunization program gaps. In the Child Health and Mortality Prevention Surveillance study in Mali, we observed a rise in under-5 measles-related deaths in 2022 that corresponded with...
4.
Patel P, Liang Y, Meiring J, Chasweka N, Patel P, Misiri T, et al.
Lancet
. 2024 Jan;
403(10425):459-468.
PMID: 38281499
Background: Randomised controlled trials of typhoid conjugate vaccines among children in Africa and Asia have shown high short-term efficacy. Data on the durability of protection beyond 2 years are sparse....
5.
Nampota-Nkomba N, Nyirenda O, Mallewa J, Chimalizeni Y, Dzabala N, Fay M, et al.
Trials
. 2024 Jan;
25(1):87.
PMID: 38279124
Background: Despite treatment with highly effective antimalarial drugs, malaria annually claims the lives of over half a million children under 5-years of age in sub-Saharan Africa. Cerebral malaria (CM), defined...
6.
Mkandawire F, Buchwald A, Nampota-Nkomba N, Nyirenda O, Zuze K, Kuria S, et al.
AIDS Care
. 2024 Jan;
:1-8.
PMID: 38184889
We evaluated detectable viral load (VL) in pregnant women established on antiretroviral therapy (ART) for at least 6 months before conception and those self-reported as ART naïve at first antenatal...
7.
Nampota-Nkomba N, Carey M, Jamka L, Fecteau N, Neuzil K
Open Forum Infect Dis
. 2023 Jun;
10(Suppl 1):S6-S12.
PMID: 37274532
Typhoid fever is a serious disease that disproportionately impacts children in low-resource settings in sub-Saharan Africa, South and Southeast Asia, and the Western Pacific. The prevalence of antimicrobial-resistant strains of...
8.
Nyangulu W, Mungwira R, Divala T, Nampota-Nkomba N, Nyirenda O, Buchwald A, et al.
Malar J
. 2023 Jan;
22(1):32.
PMID: 36707795
Background: When people with human immunodeficiency virus (HIV) infection (PWH) develop malaria, they are at risk of poor anti-malarial treatment efficacy resulting from impairment in the immune response and/or drug-drug...
9.
Nampota-Nkomba N, Nyirenda O, Khonde L, Mapemba V, Mbewe M, Ndaferankhande J, et al.
Lancet Glob Health
. 2022 Aug;
10(9):e1326-e1335.
PMID: 35961356
Background: Typhoid fever is a substantial public health problem in Africa, yet there are few clinical trials of typhoid conjugate vaccine (TCV). We assessed immunogenicity and safety of Typbar TCV...
10.
Mungwira R, Laurens M, Nyangulu W, Divala T, Nampota-Nkomba N, Buchwald A, et al.
AIDS
. 2022 Jul;
36(12):1675-1682.
PMID: 35848575
Objective: Many individuals living with the human immunodeficiency virus (HIV) infection and receiving antiretroviral therapy (ART) reside in areas at high risk for malaria but how malaria affects clinical outcomes...